within Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L01B_Antimetabolites.L01BB05_Fludarabine;

model Fludarabine
  extends Pharmacolibrary.Drugs.ATC.L.L01BB05;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>L01BB05</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Fludarabine is a purine analog used as an antineoplastic agent, primarily for the treatment of hematological malignancies such as chronic lymphocytic leukemia (CLL) and low-grade non-Hodgkin lymphoma. It is approved for clinical use and typically administered intravenously.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics reported for adult cancer patients after intravenous administration; mixed male and female population with normal renal function.</p><h4>References</h4><ol><li><p>Kuo, GM, et al., &amp; Burstein, AH (2001). Fludarabine pharmacokinetics after subcutaneous and intravenous administration in patients with lupus nephritis. <i>Pharmacotherapy</i> 21(5) 528–533. DOI:<a href=&quot;https://doi.org/10.1592/phco.21.6.528.34549&quot;>10.1592/phco.21.6.528.34549</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11349741/&quot;>https://pubmed.ncbi.nlm.nih.gov/11349741</a></p></li><li><p>Kikuchi, T, et al., &amp; Okamoto, S (2021). Pharmacokinetics of intravenous busulfan as condition for hematopoietic stem cell transplantation: comparison between combinations with cyclophosphamide and fludarabine. <i>International journal of hematology</i> 113(1) 128–133. DOI:<a href=&quot;https://doi.org/10.1007/s12185-020-02990-y&quot;>10.1007/s12185-020-02990-y</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/32886279/&quot;>https://pubmed.ncbi.nlm.nih.gov/32886279</a></p></li><li><p>Frampton, JE, &amp; Wagstaff, AJ (2003). Alemtuzumab. <i>Drugs</i> 63(12) 1229–1246. DOI:<a href=&quot;https://doi.org/10.2165/00003495-200363120-00003&quot;>10.2165/00003495-200363120-00003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/12790693/&quot;>https://pubmed.ncbi.nlm.nih.gov/12790693</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Fludarabine;
